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The establishment of a stable reservoir of latently infected cells allows HIV to persist in the host.
Usually, HIV infection of T cells results in integration of the viral genome, with a preference for regions
in the human genome containing active genes, viral expression, and production of new viruses. However,
in rare cases T cells become latently infected, and this is presumed to be due to a combination of two
factors: integrated viruses are not efficiently transcribed and infected T cells revert to a resting memory
state. HIV latency has been associated with provirus integration in regions of constitutive heterochroma-
tin, gene deserts, or very highly expressed genes. We have investigated the transcriptional consequences
of latent HIV integration into cellular genes and the involvement of chromatin reassembly factors (CRFs)
in the transcriptional interference that a host gene exerts on the integrated cryptic HIV promoter.
Chimeric transcripts containing sequences from the host gene and HIV can be detected, having been
initiated at promoters of either the cell or the virus. Reactivation of HIV downregulates host gene
expression. Cryptic promoters might remain inactive due to the repressive chromatin configuration
established by CRFs during transcription elongation. Depletion of CRFs such as Spt6, Chd1, and FACT,
or the histone chaperones ASF1a and HIRA, promoted HIV reactivation, concomitantly with chromatin
relaxation and a decrease in general RNA polymerase activity. Overall, our results indicate that CRFs play
a role in maintaining HIV latency by transcriptional interference when the provirus is integrated into an
intron of a highly active gene.
In HIV-infected individuals successfully treated with anti-
retroviral therapy (ART), viremia is controlled to undetectable
levels. Nevertheless, viremia appears rapidly after interruption
of treatment, consistent with the existence of a latent viral
reservoir. This reservoir seems to consist mainly of long-lived
latently infected resting memory CD4 T cells. The absence of
viral protein expression shields latently infected cells from the
immune system, and latently infected cells can be maintained
for years by cellular quiescence (8, 9, 20, 21, 53, 62). Antigen
stimulation or cytokine induction can reactivate the latent pro-
virus and lead to viral replication and reinfection. The pres-
ence of this reservoir prevents the eradication of the virus and
makes the infection a chronic disease. To achieve eradication
of HIV from infected patients, it may be necessary to combine
ART with drugs able to reactivate dormant viruses (55).
The establishment of HIV latency is a rare event that may
occur when infected CD4 lymphocytes stop proliferating and
become resting cells. In addition, to allow cell survival, HIV
expression should not occur after integration nor before the
cell exits the cell cycle. Latently infected cells contain replica-
tion-competent provirus blocked at the transcriptional level by
effective and reversible silencing. HIV transcription depends
on cellular factors in addition to the viral Tat (transactivator of
transcription) protein, and consequently, HIV promoter activ-
ity is tightly linked to the level of activation of its host cell. A
suboptimal cellular environment for HIV expression at the
transcriptional or posttranscriptional level contributes to the
maintenance of the latent state (molecular mechanisms of HIV
latency are reviewed elsewhere, e.g., in references 3, 11, 12,
and 35).
Chromatin plays an essential role in the transcriptional reg-
ulation of HIV (48, 50). Key regulatory nucleosomes are po-
sitioned around the HIV transcription start site (TSS) when
the promoter is inactive and are acetylated or remodeled upon
activation (41, 58). Transcription-independent nucleosome re-
arrangement and histone acetylation are assisted, respectively,
by ATP-dependent chromatin remodeling complexes and his-
tone acetyltransferases recruited, at least partially, by Tat to
the long terminal repeat (LTR) (43, 54, 56). Tat is an unusual
transcription factor in that it binds an RNA element (TAR) at
the 5 end of the viral transcript, not at a DNA binding site. Its
main role is to recruit the P-TEFb complex to the LTR to
promote efficient elongation (32, 46). Tat is absent from in-
fected cells until inefficient transcription from the HIV pro-
moter depending on host cell factors (Sp1, NF-B, NFAT,
and others) allows some synthesis of this viral protein. After
Tat is produced, HIV transcription enters a second, more
efficient phase. However, in latently infected cells, HIV
transcription is blocked at the initial phase, Tat is absent,
and chromatin is a barrier to clearance of the preinitiation
complex and polymerase progression. Previous models of
HIV latency, cell lines ACH2 and U1, harbored proviruses
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with mutations in their Tat-TAR transcriptional axis,
strengthening the idea that transcription inhibition is key to
the establishment and maintenance of HIV latency (18, 19).
Thus, a lack of specific host factors, a defective Tat-TAR
axis, and a repressive chromatin environment could contrib-
ute to postintegration latency.
HIV transcription is influenced by the site of integration in
the human genome (29). Survival of the infected cell to allow
conversion to the resting state requires integration at a
genomic site unfavorable for HIV transcription. HIV integra-
tion favors regions with active genes and active epigenetic
marks, which most commonly lead to productive infection (6,
51, 59). Rare latent infection has been associated with provirus
integration at regions of constitutive heterochromatin such as
centromeric alphoid repeats, gene deserts, or introns in very
highly expressed genes (24, 28, 39). For the integration into
heterochromatin and, probably, gene deserts, local chromatin
compaction can easily explain the silencing of the viral pro-
moter. The silenced HIV promoter has been associated with
repressive epigenetic marks, histone deacetylases (HDACs)
and methyltransferases, heterochromatin proteins, and CpG
methylation (4, 17, 26, 33, 60) and also in trans with hetero-
chromatin at the nuclear periphery (16). Transcriptional inter-
ference has been proposed as the cause of silencing of HIV
integrated at active genes (23, 25, 38, 39). Read-through tran-
scription of the host gene may prevent preinitiation complex
formation at the HIV promoter, when the host gene and the
provirus have the same or a convergent orientation. Alterna-
tively, it has been proposed that host gene transcription may
confer positive effects on HIV expression when the two are in
the same orientation (25), but this model is not consistent with
the fact that latent HIV does not exhibit a trend toward con-
vergent integration (24, 39). Discrepancies between models
may be due to position effects such as differences in the dis-
tances between transcriptional start sites and splice sites (25,
38). As active integrations are also common in introns of active
genes, various cis and trans determinants may influence
whether or not host gene transcription interferes with HIV
promoter activity and, ultimately, whether a provirus will be-
come latent.
Using a previously established model of HIV postintegration
latency consisting of the infection of Jurkat cells with a green
fluorescent protein (GFP)-encoding HIV minigenome and se-
lecting for reversible silent integrations, we investigated the
transcriptional consequences of latent HIV integration into
introns of cellular genes and the involvement of chromatin
reassembly factors (CRFs) in the transcriptional interference
that a host gene exerts on the integrated cryptic HIV promoter.
Cryptic promoters might remain inactive due to the repressive
chromatin configuration established by CRFs during transcrip-
tion elongation (7, 31, 44). We have previously demonstrated
the involvement of CRFs in the silencing of an HIV transcrip-
tional model in Saccharomyces cerevisiae (57). The present
paper reports that depletion of human CRFs such as Spt6,
Chd1, and FACT, or the histone chaperones ASF1a and
HIRA, promotes HIV reactivation, concomitantly with chro-
matin relaxation and a decrease in general RNA polymerase
activity.
MATERIALS AND METHODS
Cell lines, culturing conditions, and cell treatments. We have used a previ-
ously established model of HIV-1 latency based on the infection of Jurkat T cells
at a low multiplicity of infection (MOI) with HIV-derived particles containing
the minigenome carried on plasmid pEV731 (LTR-Tat-internal ribosome entry
site [IRES]-GFP-LTR) (28). Briefly, GFP-positive, productively infected cells
were isolated, and clones were obtained, including J-Act C9. GFP-negative cells
were treated with tumor necrosis factor alpha (TNF-), the resulting GFP-
positive, latently infected cells were isolated, and clones were generated from
single cells. J-Lat H2, A1, and A2 have been previously described (28). Clone
J-Lat E27 was newly generated in this study. Additionally, clones J-Lat 6.3 and
8.4 generated similarly with a full-length GFP-encoding HIV-1 vector (HIV-R7/
E/GFP) described elsewhere were also used (28).
Jurkat-derived cells were grown in RPMI 1640 medium (Gibco) supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100
mg/ml streptomycin at 37°C under a 5% CO2 atmosphere. When indicated,
Jurkat clones were treated with 10 nM phorbol myristate acetate (PMA; Sigma-
Aldrich), 400 nM trichostatin A (TSA; Sigma-Aldrich), 10 ng/ml TNF- (Sigma-
Aldrich), and 5 M 5-aza-2-deoxycytidine (Sigma-Aldrich) or 10 mM hexa-
methylene bisacetamide (HMBA; Sigma-Aldrich) (13).
HEK-293T cells were grown under the same conditions as those for Jurkat
cells in Dulbecco’s modified Eagle’s medium (Gibco) supplemented with 10%
fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin.
Flow cytometry analysis and sorting. GFP fluorescence was measured in a
Cytomics FC500 MPL flow cytometer (Beckman Coulter Inc., Fullerton, CA). A
two-parameter analysis was used to distinguish GFP-derived fluorescence from
background. Fluorescence was represented in logarithmic scale. The optical
alignment was set up using 10-nm fluorescent beads (Flow-Check fluorospheres;
Beckman Coulter). Cell sorting was carried out with the Moflo high-speed sorter
(Dako-Cytomation, Fort Collins, CO).
Viral production and cell infections. HEK-293T cells (Clontech) were used to
produce viral particles containing the HIV LTR-Tat-IRES-GFP minigenome
(pEV731) (29) or the pLKO.1 vector containing different short hairpin RNAs
(shRNAs; Sigma Aldrich). 293T cells (2.5  106) were transfected with the
indicated plasmid of interest (10 g), pCMVR8.91 (15 g), and pVSVG (5 g)
in 10-cm dishes using calcium phosphate. Medium was collected every 24 h for
2 days and ultracentrifuged for 1 h 30 min at 26,000 rpm and 4°C in a sucrose
gradient to concentrate the viral particles. Pellet containing the viruses was
dissolved in medium and used for the infection. Cells were infected using the
spinoculation system, with centrifugation at 1,200 rpm for 2 h at room temper-
ature. Cells infected with shRNA-expressing pLKO.1 vectors were selected with
2 mg/ml puromycin (Sigma-Aldrich) 24 h after infection.
Sequencing of flanking genomic regions and PCR products. The Genome-
Walker kit (BD Biosciences) was used to sequence flanking genomic regions
according to the manufacturer’s instructions. PCR products containing flanking
DNA were run in 1% agarose gels with ethidium bromide. Bands obtained were
purified from the gel with the QIAquick gel extraction kit (Qiagen) and se-
quenced.
RNA extraction, reverse transcription-PCR (RT-PCR), and quantitative PCR
(qPCR) for expression analysis. Total RNA was extracted using High Pure RNA
isolation (Roche) according to the manufacturer’s instructions. cDNA was ob-
tained from 100 ng of total RNA using SuperScript VILO cDNA synthesis
(Invitrogen). Indicated gene products were analyzed by PCR with specific oligo-
nucleotides, followed by visualization in an agarose gel. When indicated, quan-
tification of gene products was performed by real-time PCR using LightCycler
480 SYBR green I Master (Roche, Indianapolis, IN). Each value was corrected
by human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or 60S ribo-
somal protein L31 (RPL31) and expressed as relative units.
Analysis of chromatin accessibility to MNase. The accessibility of nucleosomal
DNA to micrococcal nuclease (MNase) was analyzed as described elsewhere
(29), using 0.4 U of MNase for 25 min. Genomic DNA was extracted using the
DNeasy blood and tissue kit (Qiagen) according to the manufacturer’s instruc-
tions. DNA was run in a 1.5% agarose gel and stained with ethidium bromide.
The band corresponding to the mononucleosome was cut and purified using the
QIAquick gel extraction kit (Qiagen), and DNA was used in a real-time PCR
with specific oligonucleotides. Naked genomic DNA was used as a control. DNA
was cut with 0.04 U MNase for 5 min, phenol precipitated, run in a 1.5% agarose
gel, and stained with ethidium bromide. DNA with a size similar to that of the
mononucleosome was cut and purified.
Sequences of shRNAs and PCR primers. Sequences of oligonucleotides used
for conventional or real-time PCR and of short-hairpin interfering RNAs are
included in Tables S1 and S2 in the supplemental material.
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Yeast experiments. The wild-type strain BY4741 and the isogenic mutants
indicated in Fig. S8 in the supplemental material were transformed with plasmids
pTy1-HIV and pTy1-HIVTARless (57) and incubated in yeast extract-peptone-
dextrose (YPD) medium until mid-log growth. RNA was extracted, and the
levels of HIV-derivative mRNAs were quantified by Northern hybridization as
described elsewhere (57).
RESULTS
Characterization of latent HIV integration into introns of
active genes. Postintegrative HIV latency has been associated
with provirus integration at regions of constitutive heterochro-
matin such as centromeric alphoid repeats, gene deserts, or
introns of very highly expressed genes (39). Four representa-
tive Jurkat-derived clones harboring a single latent version of
an HIV minigenome expressing Tat and GFP under the con-
trol of the viral 5 LTR (J-Lat) were used to further investigate
the causes of HIV promoter repression associated with the site
of integration. J-Lat H2 cells contain the HIV-derived provirus
at centromeric alphoid repeats (28), while J-Lat A1 cells har-
bor the HIV minigenome in an intergenic region at position
ChXp21.1 (16, 28), and J-Lat A2 cells contain the HIV con-
struct at intron 8 of the UTX gene (ChXp11.3), in a configu-
ration opposite to the transcriptional orientation of this gene
(Fig. 1C) (28). Finally, J-Lat E27 cells were prepared for this
study with the same HIV vector (pEV731) and procedure as
those reported previously (28). Using DNA sequencing, this
latent HIV integration was found to occur at intron 8 of the
UBXD8 or FAF2 gene (Ch5q35.2), both putatively transcrib-
ing in the same direction (Fig. 1C; see also Fig. S1 in the
supplemental material). Inducibility of the repressed HIV pro-
moter in these four clones was confirmed by treatment of J-Lat
cells with known activators of HIV expression, such as PMA,
TNF-, TSA, and HMBA and measurement of GFP expres-
sion by cell cytometry (Fig. 1A and B).
Transcriptional interference has been proposed to explain
HIV promoter repression when integrated into introns of
highly expressed genes (3, 38). To investigate the mechanism
underlying transcriptional interference and the consequences
of HIV integration into human genes and expression, we fur-
ther characterized the J-Lat clone E27 and, to some extent, the
clone A2. First, we confirmed that UBXD8 and UTX genes are
basally expressed in Jurkat cells (Fig. 1D). UBXD8 expression
has been reported to be increased by mitogenic agents such as
PMA (27). We confirmed that UBXD8 was stimulated by
PMA in Jurkat cells, but the effect was less marked in J-Lat
E27 cells. On the other hand, UTX expression was not respon-
sive to PMA in Jurkat cells but was downregulated in J-Lat A2
cells (Fig. 1E). This suggested that HIV reactivation by PMA
could influence expression of the host gene where HIV was
integrated (see below).
Next, using RT-PCR with oligonucleotides designed to cover
several gene and HIV regions, we investigated the effect of the
HIV integration into the UBXD8 gene, in terms of transcript
species generated (Fig. 2A). J-Lat E27 cells were treated or not
with PMA, and RNA was extracted and reverse transcribed
with random hexamers prior to PCR amplification. Combining
oligonucleotides for UBXD8 exon 5 and U3 of the HIV LTR,
we detected transcripts initiated at the UBXD8 promoter re-
taining intron 8 and extending into the HIV provirus, instead
of eliminating them by splicing as expected. In fact, two dif-
ferent products were detected, the second one (A2) due to the
presence of a cryptic splicing acceptor in U3 (Fig. 2A; see also
Fig. S1 in the supplemental material). These transcripts did not
necessarily terminate at the transcription stop site [poly(A)]
present in the R region of HIV LTRs, as read-through tran-
scripts were also detected (products B and C1 to C3). Interest-
ingly, splicing of read-through transcripts was enhanced by
PMA stimulation. The splicing donor present at the HIV mini-
genome was recognized, but not the canonical acceptor. In-
stead, terminal splice sites were generated at two different
cryptic sites inside the Tat-encoding sequence (see Fig. S1).
Nonetheless, when a combination of primers was used to
detect transcripts initiated at the HIV 5 LTR promoter, un-
spliced and correctly spliced transcripts were detected (PCR
products D and E), and this transcription was enhanced by
PMA treatment (Fig. 2A). An unexpected transcription prod-
uct resulting from a splicing event between the HIV splicing
donor and the acceptor at the end of the UBXD8 intron 8
(product F) (see Fig. S1 in the supplemental material) was
identified. As this was entirely dependent on the PMA treat-
ment, we speculate that it was initiated at the HIV promoter
and could be an example of downstream, truncated host gene
products generated by the insertion of lentiviruses. Finally, we
also detected the presence of read-through transcripts at the 3
LTR (product G), as well as transcripts that could be initiated
at the 3 LTR, which may also work as an inducible promoter
(product H).
Because PMA stimulates not only HIV activation but also
that of UBXD8, we explored the responses to TSA and TNF-
of some of the chimeric UBXD8-HIV RT-PCR products (Fig.
2B and C). Any of these products was enhanced by these HIV
inducers, except for the spliced products C2 and C3. This in-
dicated that transcripts containing A1 and A2, B, and C1 prod-
ucts were originated at UBXD8, but C2 and C3 may be origi-
nated by an alternative transcription start site downstream of
the NF-B binding sites present at the HIV promoter.
Quantification of transcripts initiated at HIV or host gene
promoters. These results suggested that HIV sequences could
be included in mature transcripts initiated at the UBXD8 pro-
moter or that UBXD8 downstream exons could be included in
transcripts produced due to the reactivation of 5 or 3 LTR
promoters. In order to quantify the relative frequencies of
these events, we performed quantitative PCR on synthesized
cDNA generated from J-Lat E27 cells, untreated and treated
with TNF-, which activates the HIV promoter but not
UBXD8. In order to compare different amplicons, amplifica-
tion of cDNA was corrected by amplification of genomic DNA
with the same sets of primers (Fig. 3A). This experiment
showed that there is much less transcription from UBXD8 into
the 5 LTR (amplicon intron-LTR) than transcription through
upstream exons, meaning that most of the UBXD8 transcrip-
tion would correctly splice intron 8 and the integrated HIV.
Similarly, transcripts containing part of intron 8 derived from
the HIV genome (amplicon LTR-intron) are not abundant,
although their expression significantly increased upon TNF-
treatment.
When transcription of HIV regions was analyzed, we unex-
pectedly observed that transcription from the 5 LTR pro-
moter in the absence of TNF- was considerably high, in con-
trast to the latent phenotype of these cells (GFP negative).
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FIG. 1. Characterization of latent HIV integration into introns of active genes. (A and B) Reactivation of Jurkat clones containing latent HIV
minigenome integrations in different genome environments. Cells of clones J-Lat E27, A2, H2, and A1 were incubated with PMA (10 nM), TNF-
(10 ng/ml), TSA (400 nM), or HMBA (10 mM) for 16 h, and HIV-GFP reactivation was followed by fluorescence-activated cell sorting. Data are
expressed as percentage of GFP-positive cells (%GFP) or mean fluorescence intensity (MFI). Values represent the mean and range of a
representative experiment performed in duplicate. A representative fluorescence-activated cell sorting profile and gating on J-Lat E27 are shown
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Nonetheless, the presence of Tat and GFP-encoding se-
quences in the transcripts was significantly lower, and the pres-
ence of the downstream U3 region was even lower (Fig. 3A).
Only correctly terminated transcripts may generate the GFP
products that are the basis for the definition of latent or pro-
ductive infection in this and other cellular models of latency.
Similarly, Tat expression was not detected by Western blotting
until the HIV promoter was stimulated (data not shown).
These results suggest that latency is partially produced by a
block in the elongation of HIV transcripts, as previously sug-
in panel A. (C) Intronic integration of HIV in clones J-Lat E27 and A2. Genome organization of UBXD8 and UTX genes and of the HIV
integration in J-Lat E27 and A2 clones. (D) UBXD8 and UTX are active genes in Jurkat cells. RNA was extracted from growing Jurkat cells and
used to measure expression of UBXD8, UTX, CXCR4, and PCAF genes by reverse transcription followed by real-time PCR of cDNA (RT-qPCR).
In order to compare different amplicons, qPCR was performed in parallel from genomic DNA (gDNA). Data are expressed as relative units (RU)
of cDNA amplification/gDNA amplification. Values represent the mean and standard deviation (SD) of a representative experiment performed
in triplicate. (E) Effect of PMA treatment on UBXD8 and UTX genes. Jurkat or J-Lat cells were treated or not with PMA (10 nM) for 16 h, and
RNA was extracted. UBXD8 and UTX expression was measured by RT-qPCR. GAPDH expression was measured for normalization. Data are
expressed as fold change (FC) in expression in PMA-treated cells compared to that in untreated cells.
FIG. 2. PCR-mediated identification of transcripts generated at latent HIV integration sites. (A) RNA extracted from J-Lat E27 cells treated
or not with PMA (10 nM) for 16 h was used to generate cDNA by reverse transcription with random hexamers. Several oligonucleotide
combinations were used on PCR amplification experiments to detect the appearance of different transcripts, shown in the figure below a schematic
representation (out of scale) of the HIV minigenome at the UBXD8 intron 8. The HIV integration divides intron 8 into two pieces of 404 bp
(upstream) and 1,846 bp (downstream). The positions of PCR primers used are indicated by arrows. Agarose gel electrophoresis of PCR products
illustrating each of the cDNA species is shown. When required, DNA sequencing of PCR products was applied to identify the exact nature of a
cDNA fragment (see Fig. S1 in the supplemental material). PCR amplification from genomic DNA was performed as a product size control where
indicated. (B and C) J-Lat E27 cells were treated or not with TNF- (10 ng/ml) or TSA (400 nM) for 16 h, and transcripts were characterized by
RT-PCR with the oligonucleotide pairs indicated, by conventional PCR (B) or real-time PCR (C). Primer pairs 19 plus 6 and 5 plus 6 detected
the transcript named A1, primer pair 7 plus 9 measured transcript B, and primer pair 13 plus 14 measured transcripts C.
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FIG. 3. Quantification of transcripts initiated at HIV or host gene promoters. (A) Relative quantification of transcripts generated at the HIV
integration site in clone J-Lat E27. J-Lat E27 cells were untreated or treated with TNF- (10 ng/ml) for 24 h, RNA was extracted, and gene expression
was measured by reverse transcription followed by real-time PCR of cDNA (RT-qPCR). Amplicons corresponding to 5 LTR (R-gag, primers 8 and 9
[Fig. 2A]), Tat, GFP, and 3 LTR (U3, primers 17 and 18) were used to measure HIV expression. Additionally, amplicons to measure UBXD8 expression
at exon 5 (primers 1 and 2) or expression through the boundaries of intron 8 and 5 LTR (primers 5 and 6) or 3 LTR and intron 8 (primers 8 and 10)
were used. GAPDH expression was measured for normalization. In order to compare different amplicons, qPCR was performed in parallel from genomic
DNA (gDNA). Data are expressed as relative units (RU) of (cDNA amplification/GAPDH)/gDNA amplification. Values represent the mean and range
of a representative experiment performed in duplicate. (B) HIV transcripts are generated mainly from the viral promoter. J-Lat E27 cells were untreated
or treated with PMA (10 nM) for 16 h, RNA was extracted, and transcription through the 5 LTR was measured by RT-qPCR with the oligonucleotides
indicated. GAPDH expression and qPCR from gDNA were used for normalization as in panel A. Data are expressed as in panel A. (C) Downstream
transcripts are mainly originated from 3 LTR. PMA treatment of J-Lat E27 cells was performed as in panel B, and transcription through the 3 LTR
was measured with the qPCR primers indicated. (D) Expression of downstream gene exons is induced upon HIV activation. J-Lat E27 and A2 cells were
untreated or treated with TNF- (10 ng/ml) and HMBA (10 mM) for 24 h, RNA was extracted, and transcription through UBXD8 exon 9 was measured
by RT-qPCR. GAPDH expression was measured for normalization. Data are expressed as RU of UBXD8 exon 9/GAPDH expression. In panels B to
D, values represent the mean and SD of representative experiments performed in triplicate.
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gested (1). Upon TNF- stimulation, all HIV regions were
upregulated, but a strong decrease in the presence of region
U3 in HIV transcripts was still observed (Fig. 3A). This indi-
cates that latency imposed by a transcription elongation block
could be overcome by stimulation of the HIV promoter activity
and transcriptional initiation. Similar results concerning a de-
crease in transcription along the HIV minigenome, under basal
and induced conditions, were obtained with J-Lat A2 cells and
a heterogeneous population of J-Lat cells (data not shown).
It was ascertained that HIV transcripts mainly initiated at
the HIV transcription start site, rather than at upstream
UBXD8 regions, even after PMA stimulation, by comparisons
with amplification with oligonucleotides 7 plus 9 and oligonu-
cleotides 8 plus 9 (Fig. 3B). Similarly, we showed that tran-
scription downstream of the HIV minigenome, upon stimula-
tion, mainly derived from the 3 LTR, which can act as a
promoter, not from transcripts initiated at the 5 LTR or
UBXD8 promoters unable to terminate at the 3 LTR poly(A)
sequence (Fig. 3C).
Finally, we unequivocally demonstrated that reactivation of
HIV when it is integrated cotranscriptionally into a cellular
gene may induce the expression of downstream exons. In J-Lat
E27, but not in a control clone, expression of UBXD8 exon 9
was increased by TNF- treatment, most markedly when com-
bined with HMBA, an elongation-enhancing agent (Fig. 3D).
Expression of upstream exons was not affected by the com-
bined treatment (data not shown).
HIV induction downregulates host gene expression at the
integration site. Next, we explored what effects HIV induction
might have on the expression of the host gene. Initially, we
observed that UBXD8 expression (exon 8-exon 9) was lower in
J-Lat E27 than in noninfected control cells (i.e., cells that did
not contain HIV in this cellular gene) (Fig. 4A). In Fig. 1E, we
have already illustrated the finding that PMA reactivation of
latent HIV downregulated UBXD8 in the J-Lat E27 clone and
UTX in the A2 clone, compared to parental Jurkat cells. Sim-
ilarly, TSA or TNF- induction of HIV downregulated
UBXD8 exon 8 in J-Lat E27, but not in a control clone (Fig.
4B), as well as UBXD8-HIV chimeras (Fig. 2C). As a control,
we measured expression of the wild-type (unintegrated) intron
8 allele with a primer pair that flanked the integration site. As
expected, expression was lower in J-Lat E27 (i.e., 1 intact
allele) than in A2 (i.e., 2 alleles) but was not affected by TSA
or TNF- in any case (Fig. 4A and B, right panels).
Next, we followed changes in expression of the different
regions over time after treatment of J-Lat E27 cells with PMA
or TNF- (Fig. 4C). Both treatments induced HIV (5 LTR).
As a consequence, UBXD8 (exon 5) expression, as well as
expression of chimeric transcripts entering the 5 LTR to some
extent, was downregulated upon TNF- treatment. Instead, as
PMA also activated UBXD8 (seen in the unintegrated intron
8 PCR), both effects were neutralized.
Preparation of J-Lat clone 6.3 was based on the same meth-
odology but using a full-length HIV clone (HIV-R7/E/GFP)
(28). Reactivation of HIV by TNF- plus 5-aza-2-deoxycyt-
idine in this clone, but not in a different clone, promoted
downregulation of the host gene PPP5C where HIV is inte-
grated (see Fig. S2 in the supplemental material). In the course
of our experiments, we discovered that depletion of serum
from the J-Lat cell culture medium promoted reactivation of
the HIV promoter and an increase in expression of GFP (see Fig.
S3). As a consequence, UBXD8 expression was downregulated,
specifically in the J-Lat clone E27, but not in control clones.
Taken together, our data demonstrate that HIV reactivation
negatively regulates the expression of upstream exons, presum-
ably by interfering with the activity of the host gene promoter.
This indicates that transcriptional interference might be recip-
rocal, that is, in both directions.
Depletion of chromatin reassembly factors reactivates in-
tron-integrated latent HIV concomitantly with increased chro-
matin accessibility at the HIV promoter. We have previously
suggested that depletion of cotranscriptional chromatin reas-
sembly factors (CRFs) could derepress latently integrated HIV
proviruses (57). We found that shRNA-mediated depletion of
human Spt6 and Chd1 (Fig. 5A) promoted the reactivation of
latent HIV in J-Lat clones E27 and A2 harboring the HIV
minigenome integrated into introns of active genes (Fig. 5B),
but not in clones H2 or A1, in which HIV is not integrated into
transcriptional units (Fig. 5D). Moreover, Spt6 and Chd1 de-
pletion enhanced reactivation by drug treatments such as TSA
or TNF- in the J-Lat clone E27 (Fig. 5C). Similarly, Spt6
depletion enhanced reactivation of J-Lat 8.4 cells, containing a
latent full-length HIV provirus, by TNF- plus 5-aza-2-deoxy-
cytidine (see Fig. S4 in the supplemental material). J-Lat
clones H2 and A1 were also reactivated by TNF-, but Spt6
depletion did not enhance this response (Fig. 5D). J-Act C9
contains a constitutively active version of the HIV minigenome
at an intron of the TYK2 gene (Ch19p13.2), integrated con-
trary to the direction of transcription. In this context, Spt6
depletion did not further enhance basal HIV expression or its
response to TNF- (Fig. 5D).
HIV reactivation upon depletion of Spt6 in J-Lat clones E27
and A2 was also analyzed by RT-PCR with oligonucleotides
covering different regions of the provirus (Fig. 5E). Spt6 de-
pletion enhanced transcription of the initial region of the pro-
virus by several orders of magnitude, suggesting that it favors
promoter activation and initiation, but an elongation block
remained. Nonetheless, the overall amount of terminated tran-
scripts was increased upon depletion of Spt6, and this ex-
plained the increase in GFP expression. Similarly, depletion of
Chd1 enhanced transcription initiation from the HIV pro-
moter (see Fig. S5 in the supplemental material).
CRFs travel with the elongating RNA polymerase and re-
build nucleosomes after the passage of the transcribing ma-
chinery. In the absence of Spt6, we predicted that chromatin
would become more relaxed upon transcription of UBXD8
and, consequently, the integrated HIV promoter would be
more accessible to transcription factors and preinitiation com-
plex. We investigated chromatin accessibility at the HIV pro-
moter and the UBXD8 gene using a micrococcal nuclease
(MNase) sensitivity assay. Upon MNase digestion of chroma-
tin from J-Lat E27 cells expressing Spt6 or control shRNA, the
mononucleosomal DNA was purified and the sensitivity of
different regions was assessed by quantitative PCR (qPCR)
with specific oligonucleotides (Fig. 6A and B). Regions at the
HIV promoter, presumably covered by nucleosomes, became
more sensitive to MNase upon Spt6 depletion, although not as
markedly as when optimal reactivation of HIV was promoted
by treatment with PMA, TSA, and TNF- as a control (Fig.
6A; see also Fig. S6 in the supplemental material). Increased
VOL. 85, 2011 CHROMATIN REASSEMBLY IN HIV LATENCY 3193
 o
n
 N
ovem
ber 26, 2013 by Red de Bibliotecas del CSIC
http://jvi.asm.org/
D
ow
nloaded from
 
FIG. 4. HIV induction downregulates host gene expression at the integration site. (A) UBXD8 expression in J-Lat clones. RNA from J-Lat E27
and A2 cells was extracted, and expression of the wild-type UBXD8 transcript was measured by RT-qPCR with a pair of oligonucleotides in exons
8 and 9 (19 plus 20) flanking the HIV integration site at intron 8 in J-Lat E27. As a control, expression of uninterrupted intron 8 was measured
with the primer pair 5 plus 10. GAPDH expression was measured for normalization. (B) UBXD8 expression upon HIV reactivation. J-Lat E27
and A2 cells were untreated or treated with TNF- (10 ng/ml) or TSA (400 nM) for 24 h, RNA was extracted, and transcription through UBXD8
exon 8 was measured by RT-qPCR with oligonucleotides 19 and 21 or through intact intron 8 with oligonucleotides 5 and 10. GAPDH expression
was measured for normalization. Data are expressed as fold change (FC) in UBXD8/GAPDH expression in treated cells compared to that in
untreated cells. (C) Time course response to TNF- and PMA. J-Lat E27 cells were treated with TNF- (10 ng/ml) or PMA (10 nM) for the time
points indicated in the figure, and transcription through different UBXD8-HIV regions was measured by RT-qPCR with the primer pairs indicated.
GAPDH expression was measured for normalization. Data are expressed as fold change (FC) in primer pair/GAPDH expression in treated cells
compared to that in untreated cells (time zero). Values represent the mean and range of representative experiments performed in duplicate.
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sensitivity to MNase upon Spt6 depletion was not limited to
the HIV promoter, but rather it extended to several intron and
exon regions of the UBXD8 gene upstream of the site of
integration (Fig. 6B), indicating that this was related to the
lack of proper chromatin reassembly associated with the move-
ment of the transcriptional machinery along the host gene.
According to our data shown above, HIV reactivation could
downregulate host gene expression, in particular UBXD8 ex-
pression in J-Lat E27 cells. Using RT-qPCR, we investigated
whether HIV reactivation upon Spt6 depletion affected
UBXD8 expression in this clone (Fig. 6C). Upon depletion of
Spt6, expression of UBXD8 was downregulated when oligonu-
FIG. 5. Depletion of chromatin reassembly factors reactivates intron-integrated latent HIV. (A and B) shRNA-mediated depletion of Spt6 and
Chd1 in clones J-Lat E27 and A2. Cells of the indicated latently infected clones were infected with control, Spt6, or Chd1 shRNA expression
lentiviruses (pLKO.1-Puro), and 7 days after puromycin selection, HIV-GFP reactivation was measured by fluorescence-activated cell sorting and
expressed as the percentage of cells that became GFP positive (%GFP). Depletion of these factors was tested by immunoblotting and RT-qPCR
with specific antibodies (Spt6 [ab32820; Abcam], Chd1 [H00001105-A01; Abnova]) or primers, respectively, and is shown for clone J-Lat E27 as
an example (A). (C) HIV activation by TSA or TNF- is enhanced in Spt6-depleted J-Lat cells. J-Lat E27 and A2 cells infected with control or
Spt6 shRNA expression vectors and puromycin selected for 6 days were treated or not with TSA (400 nM) or TNF- (10 ng/ml) for 24 h. HIV-GFP
expression was measured by fluorescence-activated cell sorting and was expressed as percentage of GFP-positive cells (%GFP) or mean
fluorescence intensity (MFI). (D) Spt6 depletion in nonintronic J-Lat clones. Cells of J-Lat clones H2 and A1 and of the constitutively expressing
clone J-Act C9 were infected with control or Spt6 shRNA expression lentiviruses and selected in puromycin as in panel A, and HIV-GFP
expression was measured by fluorescence-activated cell sorting. A portion of the cells were treated with TNF- (10 ng/ml) for 24 h prior to
fluorescence-activated cell sorting analysis. HIV-GFP expression is expressed as percent GFP-positive cells and as MFI for clone J-Act C9, as
percent GFP-positive cells is saturated. (E) Analysis of HIV transcription in J-Lat clones upon Spt6 depletion. Cells of J-Lat E27 and A2 clones
depleted of Spt6 as in panel A were RNA extracted, and HIV expression was measured by RT-qPCR with different amplicons covering the HIV
genome as in Fig. 3A.
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cleotides specific for upstream exons were used (exons 3 and 8)
but not when downstream exon 9 was measured, due to the
herein-reported effect of HIV activation on downstream gene
expression. In parallel, we observed that the expression of
other active cellular genes (CXCR4, CHES1, and UTX) was
also compromised by the depletion of Spt6 (Fig. 6C). More-
over, UBXD8 expression was also affected by Spt6 depletion in
a different clone (see Fig. S7 in the supplemental material).
Taken together, these findings suggest that UBXD8 downregu-
lation upon Spt6 depletion might be due not only to the reac-
tivation of HIV but also to CRFs being essential for efficient
RNA polymerase II (Pol II)-mediated transcription. As
UBXD8 downregulation in J-Lat E27 cells could diminish
transcriptional interference over the integrated HIV promoter,
this by itself could explain why depletion of Spt6 reactivated
HIV. In order to clarify whether Spt6 depletion reactivates
HIV due to a defect in cotranscriptional chromatin reassembly,
before UBXD8 expression is impaired, we performed a time
course experiment after infection with the Spt6 shRNA-ex-
pressing vector and Spt6, HIV, and UBXD8 expression was
FIG. 6. Depletion of chromatin reassembly factors reactivates HIV concomitantly with increased chromatin accessibility at the HIV promoter.
(A) Increased sensitivity of chromatin to MNase digestion upon Spt6 depletion. J-Lat E27 cells expressing control or Spt6 shRNA were submitted
to controlled MNase digestion as indicated in Materials and Methods after nucleus preparation. After purification of mononucleosomal DNA,
DNA resistance to MNase was quantified using real-time PCR and oligonucleotides covering HIV regions depicted in the schematic drawing.
Signals were normalized to naked DNA purified from the same cells before MNase digestion, PCR amplified with the same set of primers, and
to the values of PCR amplification with primers for a region considered to correspond to linker DNA free of nucleosomes. Data are expressed
as relative units of DNA resistance to MNase, i.e., (PCR amplification/linker)/gDNA. As a control, MNase resistance of chromatin in J-Lat E27
cells treated with PMA (10 nM), TSA (400 nM), and TNF- (10 ng/ml) for 4 h, compared to that in untreated cells, was also assayed and is shown
in the right panel. (B) UBXD8 chromatin sensitivity to MNase. DNA resistance to MNase at UBXD8 exon 8-intron 8 regions in J-Lat E27 cells
expressing control or Spt6 shRNA was determined as described for panel A with three pairs of specific oligonucleotides. (C) Effect of Spt6
depletion on cellular gene expression. RNA was extracted from J-Lat E27 cells expressing control or Spt6 shRNA, and expression of several genes
or the indicated exons of the UBXD8 gene was measured by RT-qPCR using specific oligonucleotides. RPL31 expression was measured for
normalization. In order to compare different amplicons, qPCR was performed in parallel from genomic DNA (gDNA). Data are expressed as
relative units (RU) of (cDNA amplification/RPL31)/gDNA amplification. (D) HIV reactivation occurs earlier than UBXD8 inhibition upon Spt6
depletion. J-Lat E27 cells were infected with control or Spt6 shRNA expression lentiviruses and selected in puromycin. At 1 or 2 days after
puromycin addition, RNA was extracted and Spt6, HIV, and UBXD8 gene expression was measured by RT-qPCR. RPL31 expression was
measured for normalization. Data are expressed as fold change (FC) of relative units (RU) of cDNA amplification/RPL31 in shSpt6 compared to
that in shControl.
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monitored by RT-qPCR. Concomitantly with Spt6 inhibition,
HIV reactivation was detected, earlier than UBXD8 down-
regulation (Fig. 6D).
Knockdown of genes required for repression of cryptic pro-
moters reactivates latent HIV. Transcriptional interference
has been proposed as an explanation of repression of cryptic
promoters from within coding regions. Several chromatin and
transcription-related factors have been identified as being in-
volved in this cotranscriptional repression in a yeast genetic
screening, including Spt6 and Chd1 (7, 31). Additional factors
identified were the histone chaperones HIR1 to -3, HPC2, and
ASF1, involved in chromatin assembly, and Spt16, a subunit of
the FACT complex, involved in nucleosome disassembly and
transcription elongation. Spt6, Chd1, and Spt16 involvement in
HIV repression was initially revealed in yeast genetic analysis
with a minimal HIV transcriptional system that was blocked
due to the assembly of a nucleosome in the initial ca. 200 bp
beyond the transcription start site (TAR-encoding region)
(57). A TAR-less promoter was derepressed. In addition, the
full-length HIV promoter was derepressed in spt6, spt16, and
chd1 genetic backgrounds, suggesting an involvement of these
factors in the nucleosome-mediated repression of the chimeric
yeast-HIV promoter. We have now assessed the involvement
of HIR1 to -3, HPC2, and ASF1 in the yeast system and found
that the deletion of any of these genes was sufficient to increase
the activity of the full-length promoter to the level of the
deleted one (see Fig. S8 in the supplemental material).
We tested the participation of the human orthologs of some
of these factors in the repression of HIV integrated at active
genes by introducing specific shRNA constructs into J-Lat
cells. Depletion of HIRA, ASF1a, and Spt16 was measured by
RT-qPCR and ranged between 75 and 95% (Fig. 7A). Upon
depletion of these three factors, HIV was reactivated in J-Lat
E27 cells, most markedly by inhibiting ASF1a expression (Fig.
7B). Comparable results were obtained by repeating this ex-
periment in the J-Lat A2 clone (data not shown) and in the
J-Lat heterogeneous population (Fig. 7C). As occurred upon
Spt6 depletion, and concomitantly with HIV reactivation by
depletion of HIRA, ASF1a, and Spt16 in the J-Lat E27 cells,
UBXD8 expression was downregulated. In a different clone,
only ASF1a depletion downregulated UBXD8 and other
genes; HIRA or Spt16 inhibition did not (see Fig. S9 in the
supplemental material), supporting the idea that reactivation
of the provirus is due not merely to downregulation of the host
genes in the knockdown.
Our results show that in certain genomic environments,
chromatin has a repressive effect on the initiation of HIV
transcription. When integrated within coding regions, CRFs
participate in the maintenance of this repressive chromatin
organization at the HIV promoter, and this could be the origin
FIG. 7. Knockdown of genes required for repression of cryptic promoters reactivates latent HIV. (A and B) J-Lat E27 cells were infected with
control, ASF1a, HIRA, or SUPT16H shRNA expression lentiviruses and selected in puromycin as described for Fig. 5A, and HIV-GFP expression
was measured by RT-qPCR with oligonucleotides 8 and 9. GAPDH expression was used for normalization. The fold change of HIV induction in
cellular factor-depleted cells compared to that in control cells is indicated. Depletion of these factors was tested by RT-qPCR with specific primers
and is shown in panel A. Values represent the mean and range of a representative experiment performed in duplicate. (C) J-Lat E27 and J-Lat
pool cells were infected with control or ASF1a shRNA as described for panels A and B, and HIV-GFP expression was measured by fluorescence-
activated cell sorting. Data are expressed as percentages of GFP-positive cells (%GFP).
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of the transcriptional interference that a transcribing unit ex-
erts on an internal promoter.
DISCUSSION
HIV transcription depends on host cellular transcription
factors and consequently on the activation state of the infected
cell, on the viral Tat protein, and on the chromatin state of the
viral promoter at the integration site. When HIV infects a
homogeneous cell population, viral expression is heteroge-
neous among individual integration events (clones) (29). This
heterogeneity can be attributed to the integration site and,
consequently, to the chromatin state of the HIV promoter that
influences the accessibility of the transcription factors and the
loading of the preinitiation complex. It cannot be ruled out
that chromatin compaction may also influence progression of
the elongating polymerase, termination, or reinitiation. HIV is
a highly effective virus that is expressed in the majority of
infected cells, allowing viral replication, presumably by inte-
gration into open chromatin represented by active genes (51,
59). Occasionally, the HIV provirus is not basally expressed but
can be reactivated by disturbing the equilibrium between acti-
vation and repression with agents that interfere with chroma-
tin, such as histone deacetylase inhibitors, or inducers of cell
signaling that activate transcription factors. This behavior re-
sembles viral latency, which in vivo certainly depends on addi-
tional components (11, 35). Analysis of the integration sites
that are associated with a latent phenotype has shown that it is
produced by integration into regions of obviously compacted
chromatin or, more importantly, into introns of highly ex-
pressed genes (24, 28, 39). It is not obvious how the chromatin
environment could be a determinant for repression when a
provirus is embedded in a transcribing gene. Instead, it has
been proposed that read-through transcription from an up-
stream promoter may interfere with HIV transcription by dis-
turbing assembly of the preinitiation complex, irrespective of
the relative orientation between the host gene and the provirus
(23, 38). Nonetheless, there have also been described situa-
tions in which upstream transcription could indeed enhance
transcription from HIV-1 proviruses that are in the same ori-
entation as the host gene (25). Position effects may explain the
discrepancy between the different models used. The mecha-
nism by which transcriptional interference is exerted has not
previously been unraveled. Here, we propose that the chroma-
tin reassembly machinery and associated factors traveling with
the elongating form of RNA polymerase II (Pol II) through the
HIV promoter actively maintain a chromatin environment re-
fractory to HIV promoter activation.
In this paper, we have addressed the question of how HIV
latency is established upon integration into a highly expressed
gene, in particular, what transcriptional consequences the pro-
virus integration has for the host genes and for the virus itself
and what host factors are involved in maintaining HIV repres-
sion in this context. For this, we have used a minimal model
system proven to be useful for studying the genomic determi-
nants of postintegration latency. Two J-Lat clones harboring
HIV integrations into introns of highly active genes, in the
same direction as or opposite to the transcription of the host
gene, have been analyzed and compared to clones where the
HIV provirus is in other genomic environments.
We observed that HIV integration into an intron of a gene
does not abolish expression of its normally spliced transcript,
although expression is diminished to some extent. Analyzing
the J-Lat clone E27, we were not able to determine the pro-
portion in which normally spliced UBXD8 transcripts derived
from the intact or the HIV-containing allele, although we have
measured expression of the unintegrated allele (intron 8) and
it was normal, proportional to the number of copies in the
genome for different clones. Host gene expression was further
decreased when HIV was reactivated, presumably at the pro-
virus-containing allele, as the unintegrated allele was not af-
fected by treatments that induce HIV (Fig. 4). Moreover, in
clone A2, as HIV is in the single-allele UTX gene (chromo-
some X), we were able to ascertain that normally spliced UTX
transcripts are being produced despite the provirus integration
but that this expression is reduced upon HIV reactivation. The
reason for this is not clear, and possible mechanisms have not
yet been investigated, but it could be due to transcription
factor or polymerase trapping by the strong initiating activity of
the HIV promoter, a putative form of transcriptional interfer-
ence. In this line, we have measured by chromatin immuno-
precipitation (ChIP) a strong recruitment of Sp1 to the HIV
LTR upon TNF- treatment (see Fig. S10 in the supplemental
material). It has recently been proposed that enhancer-block-
ers and insulators could resemble specialized promoters that
sequester the transcriptional machinery (49). The activated
HIV promoter could be acting as one of these enhancer-
blockers.
A relative comparison of transcripts representing host gene
exons or the stimulated initiating HIV indicated that HIV
transcription is comparable to or higher than host gene tran-
scription (Fig. 3). Notably, host gene downregulation is much
lower than the activation of HIV observed upon stimulation. A
limited decrease in host gene expression upon latent HIV
reactivation has been also observed in a study (38) that ana-
lyzed J-Lat clones 9.2 and 15.4 generated with a full-length,
GFP-expressing HIV genome (28). We also observed this with
the related J-Lat clone 6.3 (see Fig. S2 in the supplemental
material). In a different report, downregulation of the host
gene upon latent HIV reactivation by Tat expression was not
attributed to transcriptional interference, but rather to a Tat
effect, as it affected both alleles (15).
Lenasi et al. (38) reported that host-viral chimeric tran-
scripts at the infected allele in J-Lat 9.2 and 15.4 cells termi-
nate at the poly(A) contained in the 5 LTR (R-U5 junction).
In that case, chimeric transcripts were due to the appearance
of cryptic splicing acceptor sites at the intron preceding the 5
LTR. We have also characterized the existence of several spe-
cies of chimeric transcripts in J-Lat E27 cells extending into the
5 LTR and transcripts that cross the 5 LTR without termi-
nating at the poly(A), with different splicing variants (Fig. 2).
Similarly, we have identified transcription through the 3 LTR.
This indicates that poly(A) function is leaky; otherwise, all
transcription of the infected allele would terminate at the HIV
LTRs and no correctly spliced gene transcripts would be de-
tected. The existence of mature, chimeric transcripts contain-
ing the U3 region of the 5 LTR has been used to argue that
transcriptional interference may occur. Moreover, transcrip-
tion through the 5 LTR, presumably initiated at an upstream
host gene and terminating at the 5 LTR poly(A), can be
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detected in heterogeneous populations of HIV-infected pri-
mary T cells (38). Nonetheless, transcription interference
would still take place even if chimeric transcripts were not
detected, because the provirus-containing intron could be ef-
ficiently removed from mature transcripts and be present only
in short-lived pre-mRNAs. Relative quantification of tran-
scripts shows that chimeric transcripts are significantly less
abundant than are transcripts containing upstream exons (chi-
meric plus wild type).
Interestingly, the alternative splicing varies as a function of
PMA treatment: the intron 8/5 LTR containing the A1 band is
decreased compared to spliced A2, while the unspliced C1
product was substituted for the splicing variants C2 and C3.
Apparently, PMA stimulation of the host gene promoter favors
splicing events, although in all three cases splicing was ac-
cepted at cryptic sites, at either the 5 LTR or the Tat se-
quences. The reciprocal relationship between transcription
elongation and splicing has been extensively reported: elonga-
tion rates control alternative splicing and splicing factors can,
in turn, modulate Pol II elongation (34, 45, 52). It has to be
noted that upon TNF- treatment, HIV transcripts that initi-
ated shortly upstream of the canonical transcription start site
are detected.
Upon stimulation, transcripts initiated at the HIV 5 LTR
are produced, with several splicing variants. Unexpectedly, a
transcript that uses the HIV splicing donor and UBXD8 exon
9 acceptor is highly induced. This could explain in part why the
relative quantification of HIV transcripts covering different
regions shows that Tat, GFP, and 3 LTR are underrepre-
sented compared to the 5 LTR region (Fig. 3). Nonetheless,
an elongation block or incomplete read-through elongation
after HIV transcription initiation also seems to exist, as has
been reported previously (1, 36, 47). In agreement with this,
exogenously added Tat can reactivate latent HIV (40, 42).
Another consequence of our study is that simple measurement
of a reporter gene such as GFP is an oversimplification of the
transcriptional events taking place around the provirus.
Transcription from the 3 LTR is also induced upon cell
stimulation, being responsible for the expression of down-
stream UBXD8 exons, most strongly if elongation is stimulated
with HMBA in addition to TNF- treatment (Fig. 3). Despite
the 3 LTR being identical to the 5 LTR, its promoter activity
is always lower, basally and after induction, due to interference
of the upstream HIV promoter in the downstream LTR (14,
23). Expression of downstream host gene exons from either or
both LTRs could lead to the synthesis of truncated proteins,
this being one of the bases of the mutagenic capacity of retro-
viruses. However, this was not the case in clone E27 according
to the predictions made from the sequencing data on amplified
cDNAs.
Transcriptional interference has been proposed to explain
how a highly transcribing gene may maintain as silent a down-
stream HIV promoter leading to HIV latency. We report that
components of the machinery which reassemble chromatin
concomitantly with transit of the transcribing RNA polymerase
are necessary for the repression of the cryptic HIV promoter in
this context. Upon depletion of these factors, HIV reactivation
occurs when integrated into introns of active genes, but not for
other genome sites, concomitantly with increased chromatin
accessibility at the HIV promoter and host gene. This effect
produces synergies with other treatments that induce HIV
promoter activation and could be explored as therapeutic in-
terventions against the latent reservoir of the virus, although
the general effects of knocking down these factors on gene
expression would in principle discourage this.
The situation described here resembles the mechanism re-
ported in Saccharomyces cerevisiae to suppress cryptic tran-
scription from within coding regions. In a first report, the
transcription elongation factor Spt6 was identified as a repres-
sor of transcription initiation from cryptic promoters by main-
taining the normal chromatin structure during transcription
elongation (31). A yeast spt6 mutant permitted aberrant initi-
ation from within coding regions, and transcribed chromatin
became hypersensitive to micrococcal nuclease. Concomitantly
with activation of the cryptic promoter, the level of transcrip-
tion of the wild-type host gene decreased. More recently, a
comprehensive analysis of cryptic transcription identified at
least 50 factors, many involved in chromatin structure and
transcription, required to repress cryptic promoters through-
out the yeast genome (7). These factors would maintain the
global integrity of gene expression during normal growth but
may also allow the expression of alternative genetic informa-
tion under altered genetic or physiological conditions. These
factors include histone-encoding genes; histone regulators,
such as Hir1 to -3 or Hpc2; chromatin assembly and remodel-
ing factors, such as Spt6, Chd1, Asf1, and Spt16; histone
deacetylases and accompanying factors; components of the
mediator complex; and transcription elongation factors, such
as Spt4 and Spt5 (orthologs of subunits of the DSIF complex,
a known inhibitor of HIV elongation) (22, 46), among others.
By using a chimeric yeast-HIV promoter system, we initially
found that spt6, chd1, and spt16 mutants derepressed the viral
promoter (57). We have now added Hir1 to -3, Hpc2, and
Asf1A to the list of factors that mediate HIV repression in this
model system. RNA interference-mediated depletion of all
these factors in the human HIV latency J-Lat system shows
their involvement in the repression of HIV when integrated at
certain coding regions. Further, all these factors can be related
to the process of chromatin reassembly associated with tran-
scription elongation, either as histone chaperones or as chro-
matin remodeling or disassembly/reassembly factors. Accord-
ingly, we propose a model in which CRFs are involved in the
repression of the HIV promoter by transcriptional interference
when integrated at highly active transcription units (Fig. 8).
The transcriptional machinery elongating through a highly ex-
pressed cellular gene containing an integrated HIV provirus
includes CRFs that maintain a repressive chromatin configu-
ration. In the absence of any chromatin reassembly factor,
nucleosomes are poorly rebuilt and the chromatin configura-
tion allows transcription factors and the transcriptional ma-
chinery to access the HIV promoter. Concomitantly, host gene
expression decreases due to the global effect of CRF depletion,
contributing to a reduction in transcriptional interference, and
HIV activation further downregulates the upstream promoter.
The histone chaperone Spt6, in addition to depositing his-
tones during reassembly, is known to interact with the RNA
Pol II C-terminal domain (CTD) and Set2, a histone methyl-
transferase that methylates H3K36 through transcription elon-
gation (5, 30, 64, 65). H3K36 methylation is a mark for histone
deacetylation (37). Set2, histone deacetylases, and the histone
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modifications that they determine provide restoration of nor-
mal chromatin in the wake of elongating RNA Pol II and
prevent inappropriate initiation within coding regions masked
by chromatin. This would include initiation at the HIV pro-
moter in certain chromatin environments. In agreement with
this model, histone deacetylase (HDAC) inhibitors are known
inducers of HIV transcription (56, 63), and this is also true in
the context of the latent integrations at active coding regions
analyzed here.
CRFs participate in the mechanism that controls the equi-
librium between activation and repression of HIV when
integrated in the human genome, which depends greatly on
the chromatin environment at the integration site. Distur-
bance of this equilibrium, by depleting CRFs, for example,
makes some of the latent integrations become activated
without the need for further activating stimuli. Similarly, it
has been reported that transcriptional activators are dis-
pensable for transcription in the absence of Spt6-mediated
chromatin reassembly of particular yeast promoter regions
(2). Many of the factors involved in preventing internal
cryptic promoter initiation in yeast, including Spt2, Spt4,
Spt5, Spt6, and Spt16 (7), were originally identified in ge-
netic screening based on the yeast Ty1 retroelement (10,
61). It is, therefore, plausible that the repressive function of
CRFs to maintain the global integrity of gene expression is
conserved from yeast to humans and may have been evolu-
tionarily shaped by the selective pressure of endogenous
retroelements. It would be interesting to investigate what
the global consequences of Spt6 inhibition on the expression
and mobility of these elements are and whether the ob-
served downregulation of host genes is due to Spt6 being
essential for transcription or to side effects produced by the
induction of overlapping cryptic promoters.
Infection of T cells with an HIV vector leads to viral
expression in the vast majority of integration events. La-
tency is rare, as in the in vivo situation. Integration into
heterochromatin or gene deserts favors the establishment of
latency, but it can also occur with the integration into in-
trons of active genes (3, 39). We have found that depletion
of Spt6 reactivates latent HIV when inserted into an active
gene (J-Lat clones E27 and A2) but does not further activate
HIV in an active clone (J-Act C9) where the host gene
(TYK2) is expressed. Since we have observed TYK2 down-
regulation upon Spt6 depletion (data not shown), the ability
of CRFs to repress HIV must be context dependent. The
easiest explanation is that chromatin reassembly exerts its
repressive effect when the host gene is highly expressed and
polymerases are thoroughly reading the host gene. Accord-
ingly, in active host genes, latency seems to be favored when
they are highly expressed (3, 39). Nonetheless, local deter-
minants such as position, orientation, and distance to other
regulatory elements (enhancers, insulators, and splice sites)
may also be of consideration. After repression is set, the
situation is maintained by CRFs and histone deacetylation.
Perturbing the equilibrium of promoter chromatin leads to
HIV reactivation, but once the promoter becomes active,
these perturbations have a minor effect.
Further work is required to clarify whether, in addition to
CRFs, other cis or trans determinants may participate in tran-
scriptional interference of the viral promoter.
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